128 related articles for article (PubMed ID: 38010510)
21. Coupling of recombinant 5-lipoxygenase and leukotriene A4 hydrolase activities and transcellular metabolism of leukotriene A4 in Sf9 insect cells.
Mancini JA; Evans JF
Eur J Biochem; 1993 Dec; 218(2):477-84. PubMed ID: 8269937
[TBL] [Abstract][Full Text] [Related]
22. Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.
Mueller MJ; Wetterholm A; Blomster M; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8383-7. PubMed ID: 7667299
[TBL] [Abstract][Full Text] [Related]
23. Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.
Orning L; Krivi G; Fitzpatrick FA
J Biol Chem; 1991 Jan; 266(3):1375-8. PubMed ID: 1846352
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378.
Mueller MJ; Blomster M; Oppermann UC; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5931-5. PubMed ID: 8650196
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil LTA4 hydrolases and leukotriene B4 receptors: effects of leukotriene epoxides and their enzymatic products.
Evans J; Nathaniel D; Charleson S; Léveillé C; Zamboni R; Leblanc Y; Frenette R; Fitzsimmons BJ; Leger S; Hamel P
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):167-71. PubMed ID: 3020583
[TBL] [Abstract][Full Text] [Related]
26. Identification and subcellular localization of leukotriene A4-hydrolase activity in human epidermis.
Iversen L; Ziboh VA; Shimizu T; Ohishi N; Rådmark O; Wetterholm A; Kragballe K
J Dermatol Sci; 1994 Jun; 7(3):191-201. PubMed ID: 7918238
[TBL] [Abstract][Full Text] [Related]
27. Leukotriene A4 hydrolase as a target for cancer prevention and therapy.
Chen X; Wang S; Wu N; Yang CS
Curr Cancer Drug Targets; 2004 May; 4(3):267-83. PubMed ID: 15134534
[TBL] [Abstract][Full Text] [Related]
28. LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.
Iversen L; Deleuran B; Hoberg AM; Kragballe K
Arch Dermatol Res; 1996 May; 288(5-6):217-24. PubMed ID: 8738563
[TBL] [Abstract][Full Text] [Related]
29. Mutation of tyrosine 383 in leukotriene A4 hydrolase allows conversion of leukotriene A4 into 5S,6S-dihydroxy-7,9-trans-11,14-cis-eicosatetraenoic acid. Implications for the epoxide hydrolase mechanism.
Andberg MB; Hamberg M; Haeggström JZ
J Biol Chem; 1997 Sep; 272(37):23057-63. PubMed ID: 9287304
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of leukotriene A4 epoxide hydrolase from dog lung.
Manganaro F; Gaudette Y; Pombo-Gentile A; Singh K; Rakhit S
Prostaglandins; 1988 Dec; 36(6):859-74. PubMed ID: 2854285
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4.
Maycock AL; Anderson MS; DeSousa DM; Kuehl FA
J Biol Chem; 1982 Dec; 257(23):13911-4. PubMed ID: 6292215
[TBL] [Abstract][Full Text] [Related]
32. Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296.
Wetterholm A; Medina JF; Rådmark O; Shapiro R; Haeggström JZ; Vallee BL; Samuelsson B
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9141-5. PubMed ID: 1357660
[TBL] [Abstract][Full Text] [Related]
33. Saccharomyces cerevisiae leukotriene A4 hydrolase: formation of leukotriene B4 and identification of catalytic residues.
Kull F; Ohlson E; Lind B; Haeggström JZ
Biochemistry; 2001 Oct; 40(42):12695-703. PubMed ID: 11601994
[TBL] [Abstract][Full Text] [Related]
34. Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
Baker JR; Kylstra TA; Bigby TD
Biochem Pharmacol; 1995 Sep; 50(7):905-12. PubMed ID: 7575672
[TBL] [Abstract][Full Text] [Related]
35. Significance of leukotriene-A4 hydrolase in the pathogenesis of psoriasis.
Iversen L; Kragballe K; Ziboh VA
Skin Pharmacol; 1997; 10(4):169-77. PubMed ID: 9413890
[TBL] [Abstract][Full Text] [Related]
36. Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4 hydrolase.
Evans JF; Kargman S
FEBS Lett; 1992 Feb; 297(1-2):139-42. PubMed ID: 1312948
[TBL] [Abstract][Full Text] [Related]
37. Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations.
Thangapandian S; John S; Lazar P; Choi S; Lee KW
PLoS One; 2012; 7(7):e41063. PubMed ID: 22848428
[TBL] [Abstract][Full Text] [Related]
38. Site-directed mutagenesis of leukotriene A4 hydrolase: distinction of leukotriene A4 hydrolase and aminopeptidase activities.
Izumi T; Minami M; Ohishi N; Bito H; Shimizu T
J Lipid Mediat; 1993; 6(1-3):53-8. PubMed ID: 8358013
[TBL] [Abstract][Full Text] [Related]
39. Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase.
Evans JF; Nathaniel DJ; Zamboni RJ; Ford-Hutchinson AW
J Biol Chem; 1985 Sep; 260(20):10966-70. PubMed ID: 2993297
[TBL] [Abstract][Full Text] [Related]
40. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Byrum RS; Goulet JL; Snouwaert JN; Griffiths RJ; Koller BH
J Immunol; 1999 Dec; 163(12):6810-9. PubMed ID: 10586081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
